On Monday 24th May, External Affairs minister Dr. S Jaishankar arrived in New York for a 5 day US visit to discuss Covid Vaccines related cooperation between India and the United States. India’s Ambassador to UN TS Trimurti in a tweet conveyed that he received external affairs minister Dr. Jaishankar on his first visit to the United States after India entered the UN security council.
“Privilege to receive External Affairs Minister @DrSJaishankar on his first visit to New York after #India entered the UN #SecurityCouncil on 1 January 2021.” – Ambassador of India to UN TS Trimurti tweeted.
The External Affairs Minister will be visiting the United States from 24-28 May 2021. Dr. Jaishankar is expected to meet UNSG Antonio Guterres and is also to hold discussions with the secretary of state Antony Blinken in Washington DC, the ministry said.
As per the statement by the Ministry of External Affairs, Jaishankar will also be meeting Cabinet members and Senior Officials of the Administration dealing with the bilateral relationship. The External Affairs Minister will have two interactions with business forums on economic & COVID-related cooperation between India and the US.
The US has already announced that it is going to distribute 80 million doses of vaccine from its stockpiles to the countries in need of the vaccines. However, the details regarding the distribution have still not been confirmed by the US. Thus, Vaccine procurement will be the main agenda of discussion between Jaishankar and the US officials.
As India is fighting the second wave, the US has been playing a major role in supporting India for its fight against Covid19. Therefore, India is also looking forward to engaging in talks with US stakeholders involved in vaccine production regarding procuring and producing vaccines.
The US has already sent critical medicines like Remdesivir, Oxygen concentrators, and also the raw material for vaccine production by the Serum Institute of India currently producing Covishield. The US also has 60 million doses of AstraZeneca, Pfizer, Moderna, and also the Johnson and Johnson Vaccine in its stockpiles currently.
With several states in India struggling to provide for the lack of vaccines and acute shortages in the capital Delhi, India is desperately looking for collaborations with vaccine producers to produce vaccines in India.